Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamit Kumar

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Proteins|December 9, 2024
Conserved and Unique Mitochondrial Target Sequence of TRPV4 Can Independently Regulate Mitochondrial FunctionsTusar Kanta Acharya, Parnasree Mahapatra, Shamit Kumar, et al.
ACS Applied Bio Materials|October 10, 2024
Cytocompatible Hyperbranched Polyesters Capable of Altering the Ca<sup>2+</sup> Signaling in Neuronal Cells In VitroReetika Sarkar, Rahul Chatterjee, Sonai Dutta, et al.
Nanoscale|November 12, 2019
Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancerVijay Sagar Madamsetty, Krishnendu Pal, Sandeep Keshavan, et al.
ACS Biomaterials Science & Engineering|March 12, 2024
TRPV4 Activator-Containing CMT-Hy Hydrogel Enhances Bone Tissue Regeneration <i>In Vivo</i> by Enhancing Mitochondrial HealthSatish Kumar, Tusar K Acharya, Shamit Kumar, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 5, 2024
Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastropheHari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, et al.
Research Square|January 10, 2024
Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic CatastropheHari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, et al.
Life Sciences|October 22, 2025
From loss of Ca<sup>2+</sup>-influx to altered organelle temperature and energy failure: A neonatal-lethal TRPV4 mutant (L618P)Subham Mishra, Nishant Kumar Dubey, Nilesh Kumar Das, et al.
Molecular Pharmaceutics|May 18, 2016
Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive TumorsSujan Kumar Mondal, Sudhakar Jinka, Krishnendu Pal, et al.
Current Topics in Membranes|October 9, 2022
Function and regulation of thermosensitive ion channel TRPV4 in the immune systemTusar Kanta Acharya, Ram Prasad Sahu, Satish Kumar, et al.
Nanoscale|October 10, 2017
Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancerKrishnendu Pal, Farah Al-Suraih, Roberto Gonzalez-Rodriguez, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Proteins|December 9, 2024
Conserved and Unique Mitochondrial Target Sequence of TRPV4 Can Independently Regulate Mitochondrial FunctionsTusar Kanta Acharya, Parnasree Mahapatra, Shamit Kumar, et al.
ACS Applied Bio Materials|October 10, 2024
Cytocompatible Hyperbranched Polyesters Capable of Altering the Ca<sup>2+</sup> Signaling in Neuronal Cells In VitroReetika Sarkar, Rahul Chatterjee, Sonai Dutta, et al.
Nanoscale|November 12, 2019
Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancerVijay Sagar Madamsetty, Krishnendu Pal, Sandeep Keshavan, et al.
ACS Biomaterials Science & Engineering|March 12, 2024
TRPV4 Activator-Containing CMT-Hy Hydrogel Enhances Bone Tissue Regeneration <i>In Vivo</i> by Enhancing Mitochondrial HealthSatish Kumar, Tusar K Acharya, Shamit Kumar, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 5, 2024
Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastropheHari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, et al.
Research Square|January 10, 2024
Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic CatastropheHari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, et al.
Life Sciences|October 22, 2025
From loss of Ca<sup>2+</sup>-influx to altered organelle temperature and energy failure: A neonatal-lethal TRPV4 mutant (L618P)Subham Mishra, Nishant Kumar Dubey, Nilesh Kumar Das, et al.
Molecular Pharmaceutics|May 18, 2016
Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive TumorsSujan Kumar Mondal, Sudhakar Jinka, Krishnendu Pal, et al.
Current Topics in Membranes|October 9, 2022
Function and regulation of thermosensitive ion channel TRPV4 in the immune systemTusar Kanta Acharya, Ram Prasad Sahu, Satish Kumar, et al.
Nanoscale|October 10, 2017
Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancerKrishnendu Pal, Farah Al-Suraih, Roberto Gonzalez-Rodriguez, et al.
Pageof 4